Oudah Bashar, Abu-Abaa Mohammad, Al-Ameri Noor, Ghazaleh Jonathan, Vanam Vijay
Internal Medicine, Eisenhower Medical Center, Ranch Mirage, USA.
Internal Medicine, Capital Health Regional Medical Center, Trenton, USA.
Cureus. 2023 May 17;15(5):e39133. doi: 10.7759/cureus.39133. eCollection 2023 May.
As COVID-19 vaccines gain more prevalence, previously unrecognized side effects continue to be reported. We report a case of 78 male with no significant past medical history who was found to have a unilateral pleural effusion with symptoms that started two days after the administration of a COVID-19 vaccine. The initial presumption was bacterial pneumonia with parapneumonic effusion. However, the lack of clinical response prompted surgical intervention, and a diagnosis of empyema was established. No evidence of infectious etiology was found. This case helps to support the previously limited evidence in the recent medical literature that suggests a possible association between COVID-19 vaccines and pleurisy/effusion.
随着新冠病毒疫苗的普及，此前未被认识到的副作用仍不断有报告。我们报告一例78岁男性，既往无重大病史，在接种新冠病毒疫苗两天后出现单侧胸腔积液并伴有症状。最初推测为细菌性肺炎伴肺炎旁胸腔积液。然而，缺乏临床反应促使进行手术干预，最终确诊为脓胸。未发现感染病因的证据。该病例有助于支持近期医学文献中此前有限的证据，表明新冠病毒疫苗与胸膜炎/胸腔积液之间可能存在关联。
